| Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders |
The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
Basic net income (loss) per share: |
2024 |
|
2023 |
|
2024 |
|
2023 |
| Numerator: |
|
|
|
|
|
|
|
Net Income (loss) attributable to common stockholders |
$ |
(143,878) |
|
|
$ |
1,525 |
|
|
$ |
(361,757) |
|
|
$ |
(397,947) |
|
| Denominator: |
|
|
|
|
|
|
|
Basic weighted-average shares outstanding |
695,011,457 |
|
|
672,559,810 |
|
|
688,718,075 |
|
|
638,388,011 |
|
Basic net income (loss) per share attributable to common stockholders |
$ |
(0.21) |
|
|
$ |
0.00 |
|
|
$ |
(0.53) |
|
|
$ |
(0.62) |
|
Diluted net income (loss) per share: |
|
|
|
|
|
|
|
Numerator |
|
|
|
|
|
|
|
Net Income (loss) attributable to common stockholders |
$ |
(143,878) |
|
|
$ |
1,525 |
|
|
$ |
(361,757) |
|
|
$ |
(397,947) |
|
| Less: |
|
|
|
|
|
|
|
Income attributable to participating stockholders(1)
|
— |
|
|
(46) |
|
|
— |
|
|
— |
|
| Diluted net income (loss) attributable to common stockholders |
(143,878) |
|
|
1,479 |
|
|
(361,757) |
|
|
(397,947) |
|
| Denominator: |
|
|
|
|
|
|
|
| Number of shares used in basic net income (loss) per share computation |
695,011,457 |
|
|
672,559,810 |
|
|
688,718,075 |
|
|
638,388,011 |
|
| Weighted-average dilutive securities |
— |
|
|
18,895,352 |
|
|
— |
|
|
— |
|
| Diluted weighted-average common stock outstanding |
695,011,457 |
|
|
691,455,162 |
|
|
688,718,075 |
|
|
638,388,011 |
|
| Diluted net income (loss) per share attributable to common stockholders |
$ |
(0.21) |
|
|
$ |
0.00 |
|
|
$ |
(0.53) |
|
|
$ |
(0.62) |
|
(1) Participating securities include Earnout shares, unvested early exercised options and unvested restricted stock awards.
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive:
|
|
|
|
|
|
|
Three and Nine Months Ended September 30, 2024 |
| Common stock warrants |
28,783,069 |
|
| Unvested restricted stock units |
42,928,074 |
|
| Options to purchase common stock and unvested restricted stock awards |
13,426,025 |
|
| Total |
85,137,168 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
|
2023 |
|
2023 |
| Common stock warrants |
28,783,333 |
|
|
28,783,333 |
|
| Unvested restricted stock units |
3,596,979 |
|
|
29,342,561 |
|
| Options to purchase common stock and unvested restricted stock awards |
3,959,867 |
|
|
18,216,147 |
|
| ESPP |
— |
|
|
1,042,062 |
|
| Total |
36,340,179 |
|
|
77,384,103 |
|
|